These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 25340497)
41. Pulmonary disease and age-related macular degeneration: the Beaver Dam Eye Study. Klein R; Knudtson MD; Klein BE Arch Ophthalmol; 2008 Jun; 126(6):840-6. PubMed ID: 18541850 [TBL] [Abstract][Full Text] [Related]
42. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Tan JS; Mitchell P; Smith W; Wang JJ Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090 [TBL] [Abstract][Full Text] [Related]
43. Ten-Year Progression From Intermediate to Exudative Age-Related Macular Degeneration and Risk Factors: Bundang AMD Cohort Study Report 1. Joo K; Mun YS; Park SJ; Park KH; Woo SJ Am J Ophthalmol; 2021 Apr; 224():228-237. PubMed ID: 33279454 [TBL] [Abstract][Full Text] [Related]
44. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates. Seddon JM; Silver RE; Kwong M; Rosner B Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2192-202. PubMed ID: 25655794 [TBL] [Abstract][Full Text] [Related]
45. Incidence and progression of geographic atrophy: observations from a population-based cohort. Joachim N; Mitchell P; Kifley A; Rochtchina E; Hong T; Wang JJ Ophthalmology; 2013 Oct; 120(10):2042-50. PubMed ID: 23706948 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group. ; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM; Bressler SB Retina; 2009 Sep; 29(8):1080-90. PubMed ID: 19734762 [TBL] [Abstract][Full Text] [Related]
47. Statin use and the five-year incidence and progression of age-related macular degeneration. Klein R; Knudtson MD; Klein BE Am J Ophthalmol; 2007 Jul; 144(1):1-6. PubMed ID: 17475196 [TBL] [Abstract][Full Text] [Related]
48. Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium. Buitendijk GHS; Rochtchina E; Myers C; van Duijn CM; Lee KE; Klein BEK; Meuer SM; de Jong PTVM; Holliday EG; Tan AG; Uitterlinden AG; Sivakumaran TS; Attia J; Hofman A; Mitchell P; Vingerling JR; Iyengar SK; Janssens ACJW; Wang JJ; Klein R; Klaver CCW Ophthalmology; 2013 Dec; 120(12):2644-2655. PubMed ID: 24120328 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of Age-related Maculopathy: The Beaver Dam Eye Study. Klein R; Klein BEK; Linton KLP Ophthalmology; 2020 Apr; 127(4S):S122-S132. PubMed ID: 32200811 [TBL] [Abstract][Full Text] [Related]
50. Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study. Bastawrous A; Mathenge W; Peto T; Shah N; Wing K; Rono H; Weiss HA; Macleod D; Foster A; Burton M; Kuper H JAMA Ophthalmol; 2017 Jun; 135(6):631-638. PubMed ID: 28494075 [TBL] [Abstract][Full Text] [Related]
51. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Davis MD; Gangnon RE; Lee LY; Hubbard LD; Klein BE; Klein R; Ferris FL; Bressler SB; Milton RC; Arch Ophthalmol; 2005 Nov; 123(11):1484-98. PubMed ID: 16286610 [TBL] [Abstract][Full Text] [Related]
52. Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Knudtson MD; Klein R; Klein BE; Lee KE; Meuer SM; Tomany SC Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2135-42. PubMed ID: 15223787 [TBL] [Abstract][Full Text] [Related]
53. Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study. Klein R; Knudtson MD; Lee KE; Gangnon RE; Klein BE Ophthalmology; 2008 Sep; 115(9):1460-7. PubMed ID: 18762073 [TBL] [Abstract][Full Text] [Related]
54. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Sandberg MA; Weiner A; Miller S; Gaudio AR Ophthalmology; 1998 Mar; 105(3):441-7. PubMed ID: 9499774 [TBL] [Abstract][Full Text] [Related]
55. Measures of body shape and adiposity as related to incidence of age-related eye diseases: observations from the Beaver Dam Eye Study. Howard KP; Klein BE; Lee KE; Klein R Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2592-8. PubMed ID: 24667857 [TBL] [Abstract][Full Text] [Related]
56. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663 [TBL] [Abstract][Full Text] [Related]
57. Vitreomacular adhesion in active and end-stage age-related macular degeneration. Robison CD; Krebs I; Binder S; Barbazetto IA; Kotsolis AI; Yannuzzi LA; Sadun AA; Sebag J Am J Ophthalmol; 2009 Jul; 148(1):79-82.e2. PubMed ID: 19327744 [TBL] [Abstract][Full Text] [Related]
58. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Tan JS; Wang JJ; Flood V; Rochtchina E; Smith W; Mitchell P Ophthalmology; 2008 Feb; 115(2):334-41. PubMed ID: 17664009 [TBL] [Abstract][Full Text] [Related]
59. The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, Cataract, and Age-related Maculopathy Study. Tikellis G; Robman LD; Harper CA; Garrett SK; McNeil JJ; Taylor HR; McCarty CA Ophthalmic Epidemiol; 1999 Sep; 6(3):181-94. PubMed ID: 10487973 [TBL] [Abstract][Full Text] [Related]
60. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Robman L; Vu H; Hodge A; Tikellis G; Dimitrov P; McCarty C; Guymer R Can J Ophthalmol; 2007 Oct; 42(5):720-6. PubMed ID: 17724493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]